about
Potassium channels: novel emerging biomarkers and targets for therapy in cancer.New pyrimido-indole compound CD-160130 preferentially inhibits the KV11.1B isoform and produces antileukemic effects without cardiotoxicity.NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels.hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer.The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells.The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression.An analytical method for the quantification of hERG1 channel gene expression in human colorectal cancerThe AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemiaStromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance
P50
Q38009043-22E2C25F-0AF0-42B5-A3B2-EF60378A28C3Q38939032-4908C639-98D6-4ABD-8868-55D0F35B8771Q38979908-1D63ED5B-CDD1-4AFB-BC1E-65C61D975515Q39056231-EAAF8F22-0BC2-4111-9CF1-520808058054Q46097844-C6A57B1B-3162-41DA-9DB2-FDDBAF115ED9Q48042667-BDBAECC9-0877-4626-85D7-53D553741C0CQ86649746-186EFDAB-BD0F-45B7-AD59-A9E3021221ABQ92356480-C394467E-38AE-486A-8A2D-E99B954FA65EQ92668400-50A06F56-04B6-4267-9810-EC62E1E80C3C
P50
description
investigador
@es
researcher
@en
name
Luca Gasparoli
@en
type
label
Luca Gasparoli
@en
prefLabel
Luca Gasparoli
@en
P31
P496
0000-0002-6146-2124